Search
Displaying 1 result
Inotuzumab ozogamicin
go.drugbank.com/drugs/DB05889
ApprovedInvestigational
Inotuzumab ozogamicin is an antibody-drug conjugate consisting of a humanized IgG4 kappa CD22-targeting monoclonal antibody covalently attached to calicheamicin derivative, N-acetyl-gamma-calicheamicin dimethylhydrazide. The antibody portion of the drug binds to CD22 receptors expressed on leukemic B cells and intra...